Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: A comparative study with paroxetine and desipramine

British Journal of Pharmacology

Volumn 125, Issue 3, 1998, Pages 526-532

  Béïque, Jean Claude ^a   De Montigny, Claude ^a   Blier, Pierre ^a   Debonnel, Guy ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antidepressant; Major depression; Microiontophoresis; Reuptake inhibition

Indexed keywords

DESIPRAMINE; NORADRENALIN; PAROXETINE; SEROTONIN; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; ELECTROPHYSIOLOGY; MALE; MICROIONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CYCLOHEXANOLS; DEPRESSION; DESIPRAMINE; HIPPOCAMPUS; INJECTIONS, INTRAVENOUS; IONTOPHORESIS; MALE; NOREPINEPHRINE; PAROXETINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0031709111     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702074     Document Type: Article

References (39)

1. BENKERT, O., GRUNDER, G., WETZEL, H. & HACKETT, D. (1996). A randomized double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia. J. Psych. Res., 30, 441-451.
2. BÉÏQUE, J.C., LAVOIE, N., DE MONTIGNY, C. & DEBONNEL, G. (1998). Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur. J. Pharmacol., 349, 129-132.
3. 1A receptor agonists. J. Cardiovasc. Pharmacol., 15 (Suppl.7), 542-548.
4. BLIER, P. & DE MONTIGNY, C. (1994). Current advances and trends in the treatment of depression. Trends Pharmacol. Sci., 15, 220-226.
5. BLIER, P., DE MONTIGNY, C. & AZZARO, A.J. (1986). Modification of serotonergic and noradrenergic neurotransmission by repeated administration of monoamine oxidase inhibitors: Electrophysiological studies in the rat CNS. J. Pharmacol. Exp. Ther., 227, 987-994.
6. BOLDEN-WATSON, C. & RICHELSON, E. (1993). Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci., 52, 1023-1029.
7. CHAPUT, Y., DE MONTIGNY, C. & BLIER, P. (1986). Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 33, 342-349.
8. CUSACK, B., NELSON, A. & RICHELSON, E. (1994). Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacol., 114, 559-565.
9. DE MONTIGNY, C. (1984). Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. J. Pharmacol. Exp. Ther., 228, 230-234.
10. DE MONTIGNY, C. & AGHAJANIAN, G.K. (1978). Tricyclic antidepressants: Long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science, 202, 1303-1306.
11. DE MONTIGNY, C., WANG, R.Y., READER, T.A. & AGHAJANIAN, G.K. (1980). Monoaminergic denervation of the rat hippocampus: microiontophoretic studies on pre- and postsynaptic supersensitivity to norepinephrine and serotonin. Brain Res., 200, 363-376.
12. DE MONTIGNY, C., SILVERSTONE, P.H., DEBONNEL, G., BLIER, P. & BAKISH, D. (1998). Venlafaxine in treatment-resistant major depression: A Canadian multicentre open-label study. J. Clin. Psychopharmacol. (in press).
13. DERIVAN, A., ENTSUAH, A.R. & KIKTA, D. (1995). Venlafaxine: measuring the onset of antidepressant action. Psychopharmacology Bulletin, 31, 439-447.
14. GRAVEL, P. & DE MONTIGNY, C. (1987). Noradrenergic denervation prevents sensitization of of rat forebrain neurons to tricyclic antidepressant treatment. Synapse, 1, 133-139.
15. GUELFI, J.D., WHITE, C. & MAGNI, G. (1992). A randomized, double blind comparison of Venlafaxine and placebo in inpatients with major depression and melancholia. Clin. Neuropharmacol., 15, 19-168.
16. HADDJERI, N., BLIER, P. & DE MONTIGNY, C. (1995). Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine. Int. Clin. Psychopharmacol., 10, 11-17.
17. HOWELL, S.R., HICKS, D.R., SCATINA, J.A. & SISENWINE, S.F. (1994). Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals. Xenobiotica, 24, 315-327.
18. KANDEL, E.R. & SPENCER, W.A. (1961). Electrophysiology of hippocampal neurons. II. After potentials and repetitive firing. J. Neurophysiol., 24, 243-259.
19. KASAMO, K., BLIER, P. & DE MONTIGNY, C. (1996). Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain. J. Pharmacol. Exp. Ther., 277, 278-286.
20. KELSEY, J.E. (1996). Dose-response relationship with venlafaxine. J. Clin. Psychopharmacol., 16, 21S-28S.
21. LACROIX, D., BLIER, P., CURET, O. & DE MONTIGNY, C. (1991). Effects of long-term desipramine administration on noradrenergic neurotransmission: Electrophysiological studies in the rat brain. J. Pharmacol. Exp. Ther., 257, 1081-1090.
22. LAVOIE, N., DE MONTIGNY, C., DEBONNEL, G. & BÉIQUE, J.C. (1997). Affinities of reuptake inhibitors for the 5-HT and NE carriers: correlation with their affinities for suppressing the firing activity of 5-HT and NE neurons. Soc. Neurosci. Abstr., 23, 1109(Abstract).
23. MAES, M. & MELTZER, H.Y. (1995). The Serotonin Hypothesis of Major Depression. In Psychopharmacology: The fourth Generation of progress. eds Bloom F.E. & Kupfer D.J. New York: Raven Press, pp. 933-944.
24. MONGEAU, R., DE MONTIGNY, C. & BLIER, P. (1994a). Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology, 10, 41-51.
25. MONGEAU, R., DE MONTIGNY, C. & BLIER, P. (1994b). Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alpha-2 adrenoceptors modulating serotonin neurotransmission. J. Pharmacol. Exp. Ther., 269, 1152-1159.
26. MUTH, E.A., HASKINS, J.T., MOYER, J.A., HUSBANDS, G.E., NIELSEN, S.T. & SIGG, E.B. (1986). Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem. Pharmacol., 35, 4493-4497.
27. NELSON, J.C., MAZURE, C.M., BOWERS, M.B. & JATLOW, P.I. (1991). A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch. Gen. Psychiatry, 48, 303-307.
28. NIERENBERG, A.A., FEIGHNER, J.P., RUDOLPH, R., COLE, J.O. & SULLIVAN, J. (1994). Venlafaxine for treatment-resistant unipolar depression. J. Clin. Psychopharmacol., 14, 419-423.
29. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates. 2nd, San Diego, CA: Academic Press.
30. PIÑEYRO, G., BLIER, P., DENNIS, T. & DE MONTIGNY, C. (1994). Desensitization of the neuronal 5-HT carrier following its long-term blockade. J. Neurosci., 14, 3036-3047.
31. RANCK, J.B. (1973). Studies of single neurons in dorsal hippocampal formation and septum in unrestrained rats. I. Behavioral and firing repertoires. Exp. Neurol., 41, 461-531.
32. RICKELS, K. (1991). Venlafaxine: A new potent antidepressant agent with putative fast onset of action. Biol. Psychiatry, 1, 345-346.
33. SAMUELIAN, J.C., TATOSSIAN, A. & HACKETT, D. (1992). A randomised, double-blind, parallel group comparison of venlafaxine and clomipramine in outpatients with major depression. Clin. Neuropharmacol., 15, 324.
34. SCHATZBERG, A. & SCHILDKRAUT, J. (1995). Recent Studies on Norepinephrine Systems in Mood Disorders. In Psychopharmacology: The Fourth Generation of Progress. eds Bloom F. & Kupfer D. New York: Raven Press. pp. 911-920.
35. SCHWEIZER, E., WEISE, C., CLARY, C., FOX, I. & RICKELS, K. (1991). Placebo-controlled trial of venlafaxine for the treatment of major depression. J. Clin. Psychopharmacol., 11, 233-236.
36. SETH, R., JENNINGS, A.L., BINDMAN, J., PHILLIPS, J. & BERGMANN, K. (1992). Combination treatment with noradrenaline and serotonin reuptake inhibitors in resistant depression. Br. J. Psychiatry, 161, 562-565.
37. WANG, R.Y., DE MONTIGNY, C., GOLD, B.I., ROTH, R.H. & AGHAJANIAN, G.K. (1979). Denervation supersensitivity to serotonin in rat forebrain: single cell studies. Brain Res., 178, 479-497.
38. WEILBURG, J.B., ROSENBAUM, J.F., BIEDERMAN, J., SACHS, G.S., POLLACK, M.H. & KELLY, K. (1989). Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: A preliminary report. J. Clin. Psychiat., 50, 447-449.
39. ZAJECKA, J.M., JEFFRIESS, H. & FAWCETT, J. (1995). The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis. J. Clin. Psychiat., 56, 338-343.